Abstract
A statistical model based on four kallikrein markers (total prostate-specific antigen [tPSA], free PSA [fPSA], intact PSA, and human kallikrein-related peptidase 2) in blood can predict risk of Gleason score ≥7 (high-grade) cancer at prostate biopsy.
Original language | English |
---|---|
Journal | European Urology |
Early online date | 2015 May 12 |
DOIs | |
Publication status | Published - 2015 |
Subject classification (UKÄ)
- Urology and Nephrology